KP BIOSCIENCES, INC. — Form D/A
KP BIOSCIENCES, INC. of OREM, UT, a company, filed a Form D amendment with the SEC on 2017-02-02. The offering totals $1.2M, of which $280K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-02-02
- Form: D/A
- Accession: 0001661058-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $280K
- Remaining: $945K
- Minimum investment: $50K
- Investors: 3
- Date of first sale: 2016-01-06
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-254603
Issuer
- Name: KP BIOSCIENCES, INC.
- CIK: 0001661058
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1372 SOUTH 740 EAST, OREM, UT, 84097
- Phone: (281) 832-0050
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Robert Allen | Director | Durham, NC |
| Steve Smith | Director | Mobile, AL |
| Marc Hansen | Executive Officer | Orem, UT |
| Mark Elder | Executive Officer | Orem, UT |
| Matthew Cryer | Director | Orem, UT |
| Matthew Cryer | Executive Officer | Orem, UT |
| Kyle Lane | Director | Orem, UT |
| Kyle Lane | Executive Officer | Orem, UT |
Other filings by this issuer (2)
More